Characterizing substrate utilization during the fasted state using plasma high-resolution metabolomics.

Taibl KR, Bellissimo MP, Smith MR, Liu KH, Tran VT, Jones DP, Ziegler TR, Alvarez JA

Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide.

Pollock Y, Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik B, Olmos D, Lee JY, Uemura H, Bhaumik A, Londhe A, Rooney B, Brookman-May SD, De Porre P, Mundle SD, Small EJ

Regiochemical Switching in Ir-Catalyzed C-H Borylation by Altering Ligand Loadings of N,B-Type Diboron Species.

O'Connell AC, Mansour PA, Maleczka RE Jr, Smith MR 3rd

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.

Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Agostino RJ, Lycan T, Farris MK, Ververs J, Lo HW, Watabe K, Topaloglu U, Li W, Whitlow C, Su J, Wang G, Chan MD, Xing F, Ruiz J

Metabolic reprograming and increased inflammation by cadmium exposure following early-life respiratory syncytial virus infection-the involvement of protein S-palmitoylation.

Jarrell ZR, Lee CM, Kim KH, He X, Smith MR, Raha JR, Bhatnagasr N, Orr M, Kang SM, Chen Y, Jones DP, Go YM

Evaluation of hemostatic derangements associated with canine anaphylaxis and the relationship to syndrome severity.

Smith MR, Wurlod VA, Liu CC

The development of the Conceptual Construct Validity Appraisal Checklist.

Smith MR, Munnik E

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.

Chi KN, Sandhu S, Smith MR, Attard G, Saad M, Olmos D, Castro E, Roubaud G, Pereira de Santana Gomes AJ, Small EJ, Rathkopf DE, Gurney H, Jung W, Mason GE, Dibaj S, Wu D, Diorio B, Urtishak K, Del Corral A, Francis P, Kim W, Efstathiou E

Association between Neuroligin-1 polymorphism and plasma glutamine levels in individuals with autism spectrum disorder.

Lee IH, Walker DI, Lin Y, Smith MR, Mandl KD, Jones DP, Kong SW

PFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies.

India-Aldana S, Yao M, Midya V, Colicino E, Chatzi L, Chu J, Gennings C, Jones DP, Loos RJF, Setiawan VW, Smith MR, Walker RW, Barupal D, Walker DI, Valvi D